Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

AEMD

Aethlon Medical Inc

Dec 13 • 04:00PM ET

0.3586

Dollar change -0.0072
Percentage change -1.97	%

Healthcare • Medical Devices • USA • NASD

Peers: VXRT ALT ADMA AVDL SNGX AXSM ANVS CVM MBRX INO

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.85	Insider Own	2.33%	Shs Outstand	13.96M	Perf Week	-8.17%
Market Cap	4.91M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	0.00%	Shs Float	13.64M	Perf Month	-11.70%
Income	-11.27M	PEG	-	EPS next Q	-0.20	Inst Own	2.90%	Short Float	1.49%	Perf Quarter	-7.10%
Sales	0.00M	P/S	-	EPS this Y	80.04%	Inst Trans	124.20%	Short Ratio	0.34	Perf Half Y	-48.25%
Book/sh	0.43	P/B	0.83	EPS next Y	28.35%	ROA	-103.99%	Short Interest	0.20M	Perf Year	-79.74%
Cash/sh	0.50	P/C	0.72	EPS next 5Y	-	ROE	-137.96%	52W Range	0.24 - 2.35	Perf YTD	-83.63%
Dividend Est.	-	P/FCF	-	EPS past 5Y	37.58%	ROI	-172.96%	52W High	-84.74%	Beta	1.88
Dividend TTM	-	Quick Ratio	3.06	Sales past 5Y	24.87%	Gross Margin	-	52W Low	50.99%	ATR (14)	0.02
Dividend Ex-Date	-	Current Ratio	3.06	EPS Y/Y TTM	41.76%	Oper. Margin	-	RSI (14)	37.81	Volatility	4.07% 6.25%
Employees	14	Debt/Eq	0.13	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	2.00	Target Price	3.85
Option/Short	No / Yes	LT Debt/Eq	0.08	EPS Q/Q	83.52%	Payout	-	Rel Volume	0.22	Prev Close	0.37
Sales Surprise	-	EPS Surprise	-2.56%	Sales Q/Q	-	Earnings	Nov 13 AMC	Avg Volume	606.00K	Price	0.36
SMA20	-7.57%	SMA50	-8.56%	SMA200	-49.60%	Trades		Volume	132,781	Change	-1.97%

Dec-04-24 07:00AM	Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now (GlobeNewswire)
Dec-03-24 07:00AM	Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now (GlobeNewswire)
Nov-14-24 08:00AM	Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally (Newsfile)
02:14AM	Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ... (GuruFocus.com)
Nov-13-24 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update (PR Newswire)
08:00AM	Loading…
Nov-12-24 08:00AM	Innovative Medical Technology Advances with First Patient Enrollments (Newsfile) -7.84%
Nov-11-24 11:18AM	Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer (Medical Device Network) +5.98%
08:01AM	Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier Cancer Trial in Australia (PR Newswire)
Nov-06-24 08:01AM	Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024 (PR Newswire)
Oct-30-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now (GlobeNewswire)
Oct-29-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now (GlobeNewswire)
Oct-09-24 06:26PM	Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ... (GuruFocus.com)
Oct-08-24 08:01AM	Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit (PR Newswire) -7.03%
Sep-25-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 2 on September 26 (GlobeNewswire)
Sep-24-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now (GlobeNewswire)
08:35AM	Loading…
Sep-20-24 08:35AM	Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing (GlobeNewswire) -8.21%
Sep-19-24 10:00AM	Immunotherapy Clinical Trials - A New Approach to Treating Cancer (Newsfile) +8.82%
08:01AM	Aethlon Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India (PR Newswire)
Sep-17-24 08:01AM	Aethlon Medical to Present at Virtual Investor Conferences in September (PR Newswire)
03:30AM	Innovation Driving Cancer's Solid Tumors Market (Newsfile)
Sep-16-24 12:07PM	Life Sciences Virtual Investor Forum Agenda Announced for September 19th (GlobeNewswire)
08:01AM	Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial (PR Newswire)
Sep-13-24 08:35AM	Aethlon Medical to Present at the Life Sciences Investor Forum September 19th (GlobeNewswire)
Aug-27-24 08:01AM	Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys (PR Newswire) -7.36%
Aug-14-24 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update (PR Newswire) +15.93% -16.86%
Aug-13-24 06:53AM	Aethlon Medical receives ethics committee approval for trial of cancer treatment (Clinical Trials Arena) +6.22%
Aug-12-24 09:01AM	The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors (Newsfile)
08:01AM	Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier Cancer Trial (PR Newswire)
Aug-06-24 09:12AM	Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024 (PR Newswire) +11.54%
Jun-28-24 08:03AM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2024 Earnings Call Transcript (Insider Monkey) -13.81%
08:52PM	Loading…
Jun-27-24 08:52PM	AEMD Stock Earnings: Aethlon Medical Beats EPS for Q4 2024 (InvestorPlace)
04:15PM	Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update (PR Newswire)
Jun-21-24 08:01AM	Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 (PR Newswire)
Jun-20-24 07:00AM	What's Next in Treatments for Cancer Patients with Solid Tumors? (Newsfile) -12.59%
Jun-18-24 08:01AM	Aethlon Medical Receives Ethics Committee Approval for Hemopurifier Cancer Trial (PR Newswire) +5.37%
Jun-07-24 08:00AM	The Hunt for Virus Treatments Continues Post Covid-19 (Newsfile) +6.51%
Jun-06-24 08:12AM	Why Is Aethlon Medical (AEMD) Stock Up 82% Today? (InvestorPlace) +25.42%
07:38AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Jun-03-24 09:05AM	Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID (Newsfile) +5.26%
08:01AM	Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies (PR Newswire)
May-15-24 01:34PM	Top Midday Decliners (MT Newswires) -52.95%
09:15AM	Aethlon Medical Announces Pricing of $4.7 Million Public Offering (PR Newswire)
07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-10-24 08:01AM	Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles From Cancer Patient Plasma (PR Newswire)
Feb-21-24 08:01AM	Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices (PR Newswire)
Feb-15-24 10:03AM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript (Insider Monkey) -5.20%
Feb-14-24 04:15PM	Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update (PR Newswire)
Feb-07-24 08:00AM	Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 (PR Newswire)
Nov-16-23 09:35AM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2024 Earnings Call Transcript (Insider Monkey)
Nov-14-23 04:15PM	Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update (PR Newswire) +7.55%
Nov-13-23 08:01AM	Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (PR Newswire)
Nov-06-23 08:01AM	Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023 (PR Newswire)
Oct-12-23 10:19AM	AEMD: Authorization to Conduct Study in India Moves Oncology Initiatives Ahead (Zacks)
Oct-10-23 08:01AM	Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier in Oncology (PR Newswire)
Oct-04-23 08:01AM	Aethlon Announces Reverse Stock Split (PR Newswire) -10.86%
Aug-30-23 08:01AM	Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference (PR Newswire)
Aug-14-23 08:03AM	AEMD: Focusing on Oncology, Infectious Disease & Organ Transplants Initially (Zacks)
Aug-10-23 04:15PM	Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update (PR Newswire)
Aug-03-23 08:01AM	Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023 (PR Newswire)
Jul-24-23 08:01AM	Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant (PR Newswire)
Jul-06-23 02:17PM	Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors (PR Newswire) +25.00%
12:10PM	AEMD: Expanding Research Efforts & Strengthening Team, While Minimizing R&D Spending (Zacks)
Jun-30-23 12:42PM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.82%
Jun-28-23 04:15PM	Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update (PR Newswire) +7.85% -5.07%
Jun-22-23 08:01AM	Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023 (PR Newswire)
Jun-21-23 08:01AM	Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation (PR Newswire)
Jun-14-23 08:01AM	Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest (PR Newswire)
Jun-08-23 09:13AM	AEMD: Maximizing R&D Spending to Facilitate Clinical Efforts, Advance Hemopurifier (Zacks Small Cap Research)
Jun-01-23 03:51PM	Aethlon Medical to Present at the 13th Annual LD Micro Invitational (PR Newswire)
May-22-23 08:01AM	Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India (PR Newswire)
Feb-17-23 06:53AM	Aethlon Medical Third Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.16 loss in 3Q 2022) (Simply Wall St.)
Feb-16-23 06:52AM	Analysts Expect Aethlon Medical, Inc. (NASDAQ:AEMD) To Breakeven Soon (Simply Wall St.)
Feb-15-23 08:41AM	AEMD: New CRO to Help Advance Studies; Expanded Team to Facilitate Efforts (Zacks Small Cap Research)
Feb-14-23 04:42PM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2023 Earnings Call Transcript (Insider Monkey)
Feb-13-23 04:15PM	Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update (PR Newswire)
Jan-31-23 08:01AM	Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023 (PR Newswire) -7.55%
Jan-30-23 08:01AM	Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer (PR Newswire) +33.49%
Nov-16-22 11:10AM	AEMD: Hemopurifier Hemopurifier To Be Studied in a Variety of Solid Tumors (Zacks Small Cap Research)
Nov-14-22 04:15PM	Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update (PR Newswire) -8.34%
Nov-02-22 02:43PM	Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022 (PR Newswire) -5.61%
Sep-12-22 08:35AM	Life Sciences Virtual Investor Conference Agenda Announced for September 15th (GlobeNewswire) +9.74%
Sep-06-22 08:01AM	Aethlon Medical to Present at Two Investor Conferences in September (PR Newswire)
Aug-17-22 11:42AM	AEMD: Positive Results in a Range of Conditions, Including COVID-19 & Monkey Pox (Zacks Small Cap Research) +7.09%
Aug-15-22 08:19AM	Aethlon Medical, Inc. (NASDAQ:AEMD) Is About To Turn The Corner (Simply Wall St.)
Aug-10-22 09:13AM	10 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat (Insider Monkey)
07:38AM	Aethlon Medical To Start Lab Studies For Hemopurifier For Monkeypox (Benzinga)
Aug-09-22 04:30PM	Edited Transcript of AEMD.OQ earnings conference call or presentation 9-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents) -9.03%
04:15PM	Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update (PR Newswire)
Aug-03-22 12:47PM	Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022 (PR Newswire) -16.58%
Jul-28-22 02:01PM	Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants (PR Newswire)
Jul-11-22 08:01AM	Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment (PR Newswire)
Jun-29-22 11:25AM	AEMD: Positive Results in a Range of Conditions, Including COVID-19 & Monkeypox (Zacks Small Cap Research) +13.68%
Jun-28-22 04:15PM	Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update (PR Newswire) +10.38%
Jun-21-22 08:01AM	Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022 (PR Newswire)
May-24-22 04:21PM	/C O R R E C T I O N -- Aethlon Medical, Inc./ (PR Newswire) -9.32% -12.33%
May-21-22 09:20AM	Is Aethlon Medical (NASDAQ:AEMD) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
May-17-22 08:01AM	Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference (PR Newswire)
May-09-22 07:10AM	AEMD: Effectiveness of Hemopurifier on COVID-19 Variants In Vitro Indicates Devices Potential Range (Zacks Small Cap Research) -8.39%
May-02-22 08:01AM	Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants (PR Newswire)
Mar-28-22 08:01AM	Aethlon Medical, Inc. Appoints Angela Rossetti to Board of Directors (PR Newswire)

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AEMD

Aethlon Medical Inc

Upgrade your FINVIZ experience